NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

St. Cloud VA Health System Studies Tru-D’s Efficacy

St. Cloud VA Health Care System in St. Cloud, Minnesota, conducted a study on the effectiveness of Tru-D SmartUVC in operating rooms, endoscopy suites, urology procedure rooms and resident rooms of a community living center.

“The study demonstrated that after manual cleaning, more than half of environmental swabs grew colonies of organisms, which validates the incompleteness of manual cleaning,” said Alice Brewer, MPH, CIC, Director of Clinical Affairs for Tru-D SmartUVC. “This is consistent with other published research on the ineffectiveness of manual cleaning as a stand-alone process. Further, after using Tru-D, not a single environmental swab grew any colonies – proof that Tru-D is an exceptional adjunct to manual cleaning, and that it is capable of inactivating organisms throughout an entire room.”

Throughout the study, environmental swabs were done post-cleaning and prior to Tru-D, as well as after Tru-D was used in each room. A total of 40 environmental swabs were performed; 23 of the swabs grew organisms prior to Tru-D, and zero out of 40 swabs showed growth after the use of Tru-D. VA St. Cloud’s data confirms that Tru-D can eliminate colony growth of important pathogens in real-world settings and persuaded the facility to purchase two of the germ-killing robots.

The study also assessed ease of use and cost per patient visit. Staff were able to perform other duties while the UV cycle was running and be alerted via cellphone when the cycle was complete. Over the course of seven years, purchase price and annual service contract cost for one Tru-D machine amounted to less than six cents per outpatient visit.

The combined results of the study concluded that, “Routine use of UV disinfection is a feasible addition to current infection control and environmental management service measures and may help reduce rates of health care-associated infections and ensure our Veterans a clean, safe environment for their health care.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X